ReviewAntonie van Leeuwenhoek2026
The role of non-coding RNAs in Staphylococcus aureus infections: mechanisms, biomarkers, and therapeutic implications.
Review in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play crucial roles in regulating the host's response to Staphylococcus aureus (S. aureus) infections. These ncRNAs are involved in various biological processes, including immune regulation, inflammation, tissue repair, and apoptosis, and their dysregulation often contributes to the severity of S. aureus-induced diseases. Recent studies have highlighted the significance of ncRNAs in controlling both innate and adaptive immune responses, as well as their potential as biomarkers for disease diagnosis and prognosis. Additionally, ncRNAs are emerging as promising therapeutic targets, especially in light of the growing prevalence of antibiotic-resistant strains such as methicillin-resistant S. aureus (MRSA). However, while ncRNAs show great promise in improving treatment outcomes, much remains to be understood about their exact mechanisms in S. aureus pathogenesis. Further research into ncRNA-based therapeutic strategies is crucial to developing novel approaches for combating S. aureus infections and addressing the challenges posed by antibiotic resistance. This review emphasizes the potential of ncRNAs in S. aureus infections and their application in future therapeutic interventions.
Indexed as
Identifiers
41632381What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.